Sentence examples for a frequent marker from inspiring English sources

To determine the positive predictive value of Medicare claims for identifying revision of total hip replacement (THR), a frequent marker of THR quality and outcome.

Fli1a (friend leukemia integration 1a) is a transcription factor constitutively expressed in the endothelial cells that line adult blood and lymph vessels [39], and is a frequent marker in studies of zebrafish angiogenesis and lymphangiogenesis [40], [41].

Additionally 17/20 squamous tumors, and 2/20 for adenocarcinomas stained positively for p63 (Trp63), a protein involved in the self-renewal of stratified epithelial progenitors [22] and a frequent marker of squamous cell cancer that clusters closely with SOX2.

In this study we show that anti-NPM antibodies constitute a frequent marker in WB and MRL lpr / lpr lupus-prone mice and in human SLE, establish a clear relationship between anti-NPM and aCL antibodies and define a subset of patients with aCL antibodies.

Calretinin was a less frequent marker (Fig. 9D and E), and we could not detect colocalization with calbindin in any case (Fig. 9F).

The most frequent marker was ranked as 1st, the second most frequent marker was ranked as 2nd, and so forth.

Knee pain was the most frequent marker symptom and has been used to construct this main table.

The least frequent marker was blood glucose ≥ 110 mg/dL at 9.5 %, and 15.5 % of the participants were hypertensive.

CD20 (L26), i.e. a fundamental marker of B-lymphocytes, was described as a frequent and specific marker of the medullary type of thymoma [ 9].

On the other hand, the CD44 standard isoform (CD44s), which is known as the haematopoietic isoform, is the most frequently observed tumour-initiating cell (TIC) marker that always occurs with other frequent markers, such as CD34, CD133, ALDH, CD24, CD90, CD24, and EpCAM (Zoller, 2011).

Based on the high frequency of hypermethylation in breast cancer patients compared to healthy tissues, TAGLN promoter methylation levels can be used as an epigenetic based biomarker for diagnosis, either alone or together with other frequent markers.